ライフサイエンスコーパス: subclinical hypothyroidism

1 pothyroidism) or within the reference range (subclinical hypothyroidism).

2 cases of myxedema to more common mild forms (subclinical hypothyroidism).

3 y risk of progression among individuals with subclinical hypothyroidism.

4 dwelling adults aged 80 years and older with subclinical hypothyroidism.

5 efits in adults aged 80 years and older with subclinical hypothyroidism.

6 t AF in euthyroid participants or those with subclinical hypothyroidism.

7 d no apparent benefits in older persons with subclinical hypothyroidism.

8 othyroidism, and 18% in 141 individuals with subclinical hypothyroidism.

9 anagement of subclinical hyperthyroidism and subclinical hypothyroidism.

10 1.41% (95% CI 0.04-2.78) were found to have subclinical hypothyroidism.

11 ad subclinical hyperthyroidism, and 4.4% had subclinical hypothyroidism.

12 d normal thyroid function, 15% (n = 496) had subclinical hypothyroidism, 1.6% (n = 51) had overt hypo

13 rome were at a 21% excess risk of developing subclinical hypothyroidism (adjusted HR 1.21; 95% CI 1.0

14 These societies argue that subclinical hypothyroidism adversely affects cardiovascu

15 analysis, the odds of MCI with clinical and subclinical hypothyroidism among men was 1.02 (95% CI, 0

16 person-years of follow-up), 1958 (6.5%) had subclinical hypothyroidism and 2574 individuals (8.6%) d

17 Among 25 390 participants, 2068 (8.1%) had subclinical hypothyroidism and 648 (2.6%) had subclinica

18 were female, 21,025 were euthyroid, 1342 had subclinical hypothyroidism and 671 subclinical hyperthyr

19 is preliminary study involving patients with subclinical hypothyroidism and acute myocardial infarcti

20 Subclinical hypothyroidism and hyperthyroidism are diagn

21 strates approaches to managing patients with subclinical hypothyroidism and hyperthyroidism through 5

22 nty concerning the consequences of untreated subclinical hypothyroidism and hyperthyroidism, as well

23 significant association between clinical or subclinical hypothyroidism and MCI (odds ratio [OR], 0.9

24 s have shown an association between overt or subclinical hypothyroidism and metabolic dysfunction-ass

25 ses have demonstrated an association between subclinical hypothyroidism and metabolic syndrome and se

26 eatment might be indicated for patients with subclinical hypothyroidism and serum thyrotropin levels

27 r for young and middle-aged individuals with subclinical hypothyroidism and symptoms consistent with

28 d with a small increase in the prevalence of subclinical hypothyroidism and thyroid autoimmunity; whe

29 low birth weight (VLBW), Down syndrome (DS), subclinical hypothyroidism, and obesity.

30 : subclinical hyperthyroidism, euthyroidism, subclinical hypothyroidism, and overt hypothyroidism.

31 administration, levothyroxine in women with subclinical hypothyroidism, and the combination of aspir

32 thyroid function within the normal range or subclinical hypothyroidism are also associated with AF.

33 id diseases--subclinical hyperthyroidism and subclinical hypothyroidism--are common clinical entities

34 Some authors have defined subclinical hypothyroidism as a serum TSH between 5 and

35 s a thyrotropin level lower than 0.56 mIU/L, subclinical hypothyroidism as a thyrotropin level higher

36 lating hormone (TSH) 0.45 to 4.49 mIU/L, and subclinical hypothyroidism as TSH 4.5 to 19.9 mIU/L with

37 sm was defined as TSH of 0.45 to 4.49 mIU/L, subclinical hypothyroidism as TSH of 4.5 to 19.9 mIU/L,

38 For subclinical hypothyroidism (based on thyroid-stimulating

39 Subclinical hypothyroidism, commonly considered an early

40 and 0.90 (95% CI, 0.77-1.05) for those with subclinical hypothyroidism compared with individuals wit

41 n pregnancy before 20 weeks of gestation for subclinical hypothyroidism, defined as a thyrotropin lev

42 Subclinical hypothyroidism, defined as an elevated serum

43 adults aged 65 years or older diagnosed with subclinical hypothyroidism, defined as the presence of p

44 thyroidism should be treated, but those with subclinical hypothyroidism do not always benefit from tr

45 It found adequate evidence that treating subclinical hypothyroidism does not provide clinically m

46 ic type, both in normal thyroid group and in subclinical hypothyroidism group (40.4% and 46.7%, respe

47 Specifically, individuals with subclinical hypothyroidism had an adjusted hazard ratio

48 ral small, randomized trials of treatment of subclinical hypothyroidism have been done, but the resul

49 For participants with subclinical hypothyroidism, HRs from higher-quality stud

50 outine use of levothyroxine for treatment of subclinical hypothyroidism in adults aged 80 years and o

51 on that subclinical thyroid dysfunction, and subclinical hypothyroidism in particular, is associated

52 These findings do not support treatment of subclinical hypothyroidism in patients with acute myocar

53 Subclinical hypothyroidism in patients with acute myocar

54 an overestimation of the true prevalence of subclinical hypothyroidism in persons older than 70 year

55 Effects of thyroid autoimmunity and subclinical hypothyroidism in pregnancy remain controver

56 The biochemical definition of subclinical hypothyroidism is a matter of debate.

57 unrecognized subclinical hyperthyroidism or subclinical hypothyroidism is associated with other card

58 Subclinical hypothyroidism is common and most individual

59 The use of levothyroxine to treat subclinical hypothyroidism is controversial.

60 Subclinical hypothyroidism is defined as an elevation in

61 Subclinical hypothyroidism is known to be associated wit

62 Subclinical hypothyroidism is more common than is overt

63 Subclinical hypothyroidism is most often caused by autoi

64 Subclinical hypothyroidism may be associated with an inc

65 Subclinical hypothyroidism may be associated with depres

66 In addition, middle-aged patients with subclinical hypothyroidism may have cognitive impairment

67 A total of 427 participants with subclinical hypothyroidism (mean [SD] age, 74.52 [6.29]

68 res did not differ between participants with subclinical hypothyroidism (mean difference = 0.29, 95%

69 Treatment for subclinical hypothyroidism or hypothyroxinemia beginning

70 atment of women who are identified as having subclinical hypothyroidism or hypothyroxinemia during pr

71 ewise, there were no differences between the subclinical hypothyroidism or overt hypothyroidism group

72 rolled studies of treatment in patients with subclinical hypothyroidism or subclinical hyperthyroidis

73 niversal screening of all pregnant women for subclinical hypothyroidism or thyroid autoimmunity is no

74 so explored: iodide might be associated with subclinical hypothyroidism particularly in higher iodine

75 For patients with subclinical hypothyroidism, recommendations for therapy

76 scuss their perspectives on whether treating subclinical hypothyroidism reduces morbidity and mortali

77 sought to evaluate the relationship between subclinical hypothyroidism (SCH) and all-cause and cardi

78 Subclinical hypothyroidism (SCH) is a common endocrine d

79 heir prognostic utilizations in asymptomatic subclinical hypothyroidism (SCH).

80 prove hypothyroid symptoms among adults with subclinical hypothyroidism (SCH).

81 crease the risk of atrial fibrillation (AF), subclinical hypothyroidism (SH) is an often-underreporte

82 In subclinical hypothyroidism, the presence of depressive s

83 least 65 years of age and who had persisting subclinical hypothyroidism (thyrotropin level, 4.60 to 1

84 levothyroxine therapy in older persons with subclinical hypothyroidism to reduce the risk of develop

85 f prescribing levothyroxine in patients with subclinical hypothyroidism to reduce the risk of develop

86 nvolving adults aged 80 years and older with subclinical hypothyroidism, treatment with levothyroxine

87 In the subclinical hypothyroidism trial, the median IQ score of

88 Replacement for Untreated Older Adults with Subclinical Hypothyroidism (TRUST) trial, a double-blind

89 A total of 677 women with subclinical hypothyroidism underwent randomization at a

90 ot on treatment, the prevalence of overt and subclinical hypothyroidism was 0.82% and 6.06%, respecti

91 Subclinical hypothyroidism was associated with borderlin

92 quality cohort study found that treatment of subclinical hypothyroidism was associated with decreased

93 mponents were analyzed, an increased risk of subclinical hypothyroidism was associated with high bloo

94 hort of elderly people, neither clinical nor subclinical hypothyroidism was associated with MCI.

95 Subclinical hypothyroidism was defined as TSH between 4.

96 Clinical and subclinical hypothyroidism were ascertained from a medic

97 Clinical and subclinical hypothyroidism were associated with worse Gl

98 n depressive symptom scores in patients with subclinical hypothyroidism were limited by small sample

99 llow-up of 4.2 years, the incident rates for subclinical hypothyroidism were substantially higher in

100 yndrome are at a greater risk for developing subclinical hypothyroidism, while its mechanisms and tem

101 Association of clinical and subclinical hypothyroidism with MCI.

102 An association of clinical and subclinical hypothyroidism with mild cognitive impairmen

103 a stronger association with overt than with subclinical hypothyroidism, with ORs of 1.77 (95% CI, 1.